CRISPR diagnostics (CRISPR-Dx) offer a wide range of enhancements compared to
traditional nanobiosensors by taking advantage of the excellent trans-cleavage activity of the …

On-site and real-time clinical monitoring have been progressed dramatically by integrating
biosensor science with portable digital electronic technology. Clustered regularly …

The CRISPR/Cas technology, derived from an adaptive immune system in bacteria, has
been awarded the Nobel Prize in Chemistry in 2020 for its success in gene editing …

Infectious pathogens cause severe human illnesses and great deaths per year worldwide.
Rapid, sensitive, and accurate detection of pathogens is of great importance for preventing …

With the move of molecular tests from diagnostic labs to on-site testing becoming more
common, there is a sudden rise in demand for nucleic acid-based diagnostic tools that are …

Pathogenic biosafety is a worldwide concern. Tools for analyzing pathogenic biosafety, that
are precise, rapid and field-deployable, are highly demanded. Recently developed …

Taking advantage of the excellent trans-cleavage activity, CRISPR-based diagnostics
(CRISPR-Dx) has shown great promise in molecular diagnostics. However, the single …

Due to their superiority in the simple design and precise targeting, clustered regularly
interspaced short palindromic repeats (CRISPR)‐Cas systems have attracted significant …

Biosensing based on CRISPR-Cas systems is a young but rapidly evolving technology. The
unprecedented properties of the CRISPR-Cas system provide an innovative tool for …

Various non-nucleic acid targets (ions, small molecules, polysaccharides, peptides/proteins/
enzymes, cells, transcription factors) are important biomarkers. They play important roles in …